Skip to main content
hello world

Closing Bell: Medicenna Therapeutics Corp up on Friday (MDNA)

Automated Summaries - The Globe and Mail - Fri Jul 26, 4:01PM CDT

Today in trading, Medicenna Therapeutics Corp shares closed at $2.22 after opening the day at $2.14. prices ranged from a low of $2.13 to a high of $2.24.

Shares advanced 4.23 percent from the previous day's close of $2.13.

During the day across North America, the TSX Composite closed 0.91% at 22814.81, the S&P 500 closed -0.51% at 5399.22, the Dow Jones Industrial Average closed 0.20% at 39935.07 and the Nasdaq Composite closed -0.93% at 17181.72.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

Trading volume was 98,609 on 224 total trades, while having an average volume of 84,357 over the last 5-days.

The TSX overall saw 3,857 price advancers against 1,325 declines and 128 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 289.47% in the last year, while this year, they have risen 428.57%.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $159.28 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp's average recommendation is "Strong Buy" based on 2.00 analysts according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..